| 16 Sept. | 14:00 - 15:30 | |||
| ROOM 17 | |||||||
![]() |
|||||||
| HEALTH & NANOMEDICINE |
|||||||
![]() |
|||||||
| ADDITIVE & 3D MANUFACTURING | |||||||
| TT.III - Technical Parallel Track Sessions | |||||||
| Bridging the gap: 3D and advanced models for nanomedicine and tissue regeneration | |||||||
| Co-organised with University of Magna Graecia Chairs: Laura CATENACCI & Michela SORRENTI, University of Pavia |
|||||||
|
This session will explore the integration of advanced experimental models and nanotechnology to bridge the gap between fundamental research and biomedical applications. Particular attention will be given to innovative in vitro and preclinical models, advanced delivery platforms, and emerging approaches for studying biological interactions, tissue regeneration, and therapeutic responses. The session will highlight how physiologically relevant models can support the development, evaluation, and translation of novel nanomedicine-based strategies. |
|||||||
| The symposium is part of FE.I | |||||||
| TT.III.G.1 FE.I.6.1 |
Sara PERTEGHELLA, University of Pavia, Department of Drug Sciences In vitro models for nose-to-brain delivery studies applied to nanoformulations Virginie SOTTILE - CV, University of Pavia, Department of Molecular Medicine Preclinical models of stem cell differentiation and tissue formation |
![]() |
![]() |
||||
| TT.III.G.2 FE.I.6.2 |
Edoardo BERTANIA - CV University of Piemonte Orientale One platform, multiple carriers: microfluidics for nanoparticle- and vesicle-based drug delivery |
![]() |
|||||
| TT.III.G.3 FE.I.6.3 |
Sofia BELLIA - CV University of Palermo Nanomedicine for brain drug delivery: from design to microfluidic and 3D neurospheroid models |
![]() |
|||||
| TT.III.G.4 FE.I.6.4 |
Rachele ROSSI - CV University of Pavia Nucleic acid-loaded lipid nanoparticles optimization and interaction with biological substrates |
![]() |
|||||
| TT.III.G.5 FE.I.6.5 |
Federica TIBERIO - CV Università Cattolica del Sacro Cuore Nano-ink–mediated RNA therapy for non-invasive treatment of craniofacial disorders |
![]() |
|||||
| Back to Fields & Topics | Back to Plan 16 September | ||







